The U.S. Food and Drug Administration (FDA) has approved an injectable form of Bristol Myers Squibb's (NYSE:BMY) blockbuster cancer drug, Opdivo, the agency announced Friday. This new formulation ...

A U.S. appeals court has revived a whistleblower lawsuit accusing Swiss pharmaceutical giant Novartis (NYSE:NVS) of illegally incentivizing doctors to prescribe its multiple sclerosis drug, Gilenya.

RADCOM (NASDAQ:RDCM), a global leader in cloud-native service assurance and customer experience management solutions, announced today that it has entered into a multi-year agreement worth a low ...

Brazil’s proposed ban on self-custodial stablecoin transfers could further drive decentralisation, according to industry experts. Banco Central do Brasil (BCB) recently announced a proposal to prevent ...

Elon Musk has expressed that he would be “shocked” if U.S. President Joe Biden does not grant a pardon to Sam Bankman-Fried (SBF), the former CEO of FTX , amid growing speculation surrounding the ...

Bitcoin (CRYPTO:BTC) is experiencing significant fluctuations, ranging between $92,500 and $94,000, as the largest bitcoin options expiry in history approaches. This Friday, $14 billion in open ...

Global Data Centre Group (ASX:GDC) has confirmed the completion of its divestment from AirTrunk, following the announcement of its indirect investment in the company on Sept. 9. The Group anticipates ...

Tether (CRYPTO:USDT) is expected to end 2024 with net profits exceeding $10 billion, according to its CEO, Paolo Ardoino. Over the course of the year, Tether’s market valuation grew by around $50 ...

GenusPlus Group (ASX:GNP), a provider of essential power and communications infrastructure, has been awarded a contract for Stage 1 of the North West Transmission Developments Project by TasNetworks.

Talius Group (ASX:TAL) has secured a $2.5 million strategic placement of new fully paid ordinary shares to Stephen Norris Technologies. At $0.009 per share, this placement is made at a 7.7% premium to ...

AVITA Medical announced that the US Food and Drug Administration has approved its RECELL GO mini. This new product is an extension of the RECELL GO system, designed specifically to optimise treatment ...

The U.S. Food and Drug Administration (FDA) has revoked the emergency use authorization (EUA) for four COVID-19 antibody-based therapies, including treatments from Eli Lilly (NYSE:LLY), Regeneron ...